ArticleFrontiers in pharmacology2026

Adverse events associated with targeted therapy and immunotherapy for ovarian cancer: a FAERS pharmacovigilance study.

Kui Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.